Contents

Current Medicinal Chemistry - Anti-Cancer Agents, Volume 4 - Number 5

Preface [Hot Topic: Special Editorial Board Issue (Guest Editor: Christian Bailly)]

, 4(5): i

Christian Bailly


DOI: 10.2174/1568011043352759




Antitumor Pharmacology - Quo Vadis ?

, 4(5): 389 - 391

Christian Bailly, Jean-Marc Barret and Anna Kruczynski


DOI: 10.2174/1568011043352849




A Rational Selection of Drug Targets Needs Deeper Insights into General Regulation Mechanisms

, 4(5): 393 - 394

Giovanni Capranico


DOI: 10.2174/1568011043352821




Prospects for Hypoxia-Activated Anticancer Drugs

, 4(5): 395 - 399

William A. Denny


DOI: 10.2174/1568011043352812




Modelling and Simulation: A Computational Perspective in Anticancer Drug Discovery

, 4(5): 401 - 403

Federico Gago


DOI: 10.2174/1568011043352786




Antifolates - Past, Present and Future

, 4(5): 405 - 410

Aleem Gangjee and Hiteshkumar D. Jain


DOI: 10.2174/1568011043352803




Monoclonal Antibodies in Cancer Therapy

, 4(5): 411 - 414

Barbara Gatto


DOI: 10.2174/1568011043352713




Amplification of Anticancer Drug-Induced DNA Damage and Apoptosis by DNA-Binding Compounds

, 4(5): 415 - 419

Shosuke Kawanishi and Yusuke Hiraku


DOI: 10.2174/1568011043352867




Novel Molecular Targets in Cancer Chemotherapy Waiting for Discovery

, 4(5): 421 - 423

Conrad Kunick


DOI: 10.2174/1568011043352858




Anticancer Agents: Towards the Future

, 4(5): 425 - 427

Manlio Palumbo


DOI: 10.2174/1568011043352731




Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints

, 4(5): 429 - 434

Yves Pommier


DOI: 10.2174/1568011043352777




Combining DNA Damaging Agents and Checkpoint 1 Inhibitors

, 4(5): 435 - 438

Michelle Prudhomme


DOI: 10.2174/1568011043352795




G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase Inhibitors

, 4(5): 439 - 443

Jean-Francois Riou


DOI: 10.2174/1568011043352740




Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave

, 4(5): 445 - 447

Edward A. Sausville


DOI: 10.2174/1568011043352876




Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

, 4(5): 449 - 455

Tomi K. Sawyer


DOI: 10.2174/1568011043352830




Resistance in Cancer: A Target for Drug Discovery

, 4(5): 457 - 460

Mark Searcey and Laurence H. Patterson


DOI: 10.2174/1568011043352722




Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis

, 4(5): 461 - 463

Francois Martin and Eric Solary


DOI: 10.2174/1568011043352768




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science